Restricted accessResearch articleFirst published online 1996-05
Comparative Assessment of the Effects of Vasodilators on Peripheral Vascular Reactivity in Patients with Systemic Scleroderma and Raynaud's Phenomenon: Color Doppler Flow Imaging Study
The aim of the present study was assessment of peripheral vascular reactivity during cold test and effects of different types of vasodilators on vascular resistance in patients with progressive systemic sclerosis and Raynaud's phenomenon with use of color Doppler flow imaging of upper extremity.
Get full access to this article
View all access options for this article.
References
1.
Kallenberg C. , Wouda A., Hanw T.: The systemic involvement and immunologic findings in patients presenting with Raynaud's phenomenon. Am J Med69:675-680, 1980.
2.
Bimant J., Ginzler E., Schlesinger M., et al: The clinical significance of Raynaud's phenomenon in systemic lupus erythematosus. Arthritis Rheum22:815-819, 1979.
3.
Fitzgerald O. , Hess E., O'Connor GT, et al: Prospective study of the evaluation of Raynaud's phenomenon. Am J Med84:718-726, 1988.
4.
Le Roy EC: Scleroderma (systemic sclerosis). In: Textbook of Rheumatology , ed. by Kelly WN, Harris EB, Ruddly S, et al. Philadelphia: WB Saunders, 1985, pp1183-1205.
5.
Gerbracht D. , Steen VD, Ziegler GL, et al: Evaluation of primary Raynaud's phenomenon (Raynaud's disease) to connective tissue diseases. Arthritis Rheum28:87-92, 1985.
6.
Steen V.: Treatment of systemic sclerosis: Curr Opin Rheumatol3:979-985, 1991.
7.
Glikson M., Pollack A., Dresser-Feigin R., et al: Nifedipine and prazosin in the treatment of pulmonary hypertension in CREST syndrome. Chest98:759-761, 1990.
8.
Lau CS, Belch JJ, Madhok R., et al: A randomized, double-blind study of cicaprost, an oral prostacyclin analogue, in the treatment of Raynaud's phenomenon secondary to systemic sclerosis . Clin Exp Rheumatol11:35-40, 1993.
9.
Wigly FM, Wise RA, Seibold JR, et al: Intravenous illoprost infusion in patients with Raynaud's phenomenon secondary to systemic sclerosis. A multicenter, placebo-controlled, double-blind study. AmIntern Med120:199-206, 1994.
10.
Frager S., Pignatorco M., Anderson J., et al: Color flow Doppler: Imaging of upper extremity. J Hand Surg18a:621-625, 1993.
11.
Geirsson AJ , Jonsson GS, Asgeirsdottir LP: Functional study of the dermal microcirculation in the systemic sclerosis. Scand J Rheumatol23:73-76, 1994.
12.
Binaghi F., Canna SF, Mathien A., et al: Correlations among capillaroscopic abnormalities, digital flow and immunologic findings in patients with isolated Raynaud's phenomenon. Can laser Doppler flowmetry help identify a secondary Raynaud's phenomenon ? Int Angiology, 1992; 11:186-194, 1992.
13.
Gill RW: Measurement of blood flow by ultrasound: Accuracy and sources of error. Ultrasound Med Biol11:625-641, 1985.
14.
Subcommittee for scleroderma. Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee : Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum23:581-590, 1980.
15.
Rother E., Galle J., Peter HH: Secondary Raynaud's Phenomenon. Immun-Infect21:59-63, 1993.
16.
Engelhart M. , Kristenson JK: Local and central ortho-static sympathomimetic reflexes in Raynaud's phenomenon. Scand J Clin Lab Invest51:191-196, 1991.
17.
Blann AB, Illingwoth K., Jayson MT: Mechanisms of endothelial cell damage in systemic sclerosis and Raynaud's phenomenon. J Rheumatol, 20:1325-1330, 1993 .
18.
Sfikakis PP, Kyriakidis MK, Vergos CG, et al: Cardiopulmonary hemodynamics in systemic sclerosis and response to nifedipine and captopril. Am J Med90:541-546, 1991.
19.
Kazam E., Caidahl K., Hilgren R., et al: Noninvasive evaluation of long-term cardiac effects of captopril in systemic sclerosis. J Intern Med230:203-212, 1991.
20.
Niarchos AP , Whitman HH, Goldstein JE, et al: Hemodynamics effects captopril in pulmonary hypertension of collagen vascular disease. Am Heart J104:834-838, 1982.
21.
Engelhart M. , Seibold JR: The effects of local temperature versus sympathetic tone on digital perfusion in Raynaud's phenomenon. Angiology41:715-723, 1990.
22.
Hondeghem LM, Katzung BG: Control of vascular smooth muscle contractility and the action of calcium channel blockers. In: The Regulation of Heart Function, ed. by Rupp H.New York: Thieme, 1986, pp38-52.
23.
Lijnen P., Fagard K, Staessen, et al: Role of various vasopressor systems in the acute hypotensive effect of captopril in man. Eur J Clin Pharm20:1, 1981.
24.
Nishimura H. , Kubo S., Hayano M., et al: Peripheral hemodynamics effects of captopril in patients with congestive heart failure. Am Heart J117:100-105, 1989.
25.
Voet B., Afschrift M., Duprez B., et al: Influence of isosorbide dinitrate on superior mesenterlc artery impedance in humans. Cardiovasc Drugs and Therapy7:169-174, 1993.
